Susquehanna International Group
ANEB

Susquehanna International Group’s Anebulo Pharmaceuticals ANEB Stock Holding History

Susquehanna International Group’s Portfolio ANEB Stock Details ANEB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-25,253
Closed -$72.5K – 11965
2024
Q1 		$72.5K Buy
+25,253
New +$65K ﹤0.01% 11387

Other funds holding ANEB

2L
22NW LP Seattle, Washington $146M AUM 29.83% 1-Year Est. Return
LA
LVW Advisors Pittsford, New York $1.16B AUM 26.37% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Susquehanna International Group's ANEB Position: Q2 2024 in Review

Susquehanna International Group sold out of Anebulo Pharmaceuticals (ANEB) in Q2 2024, closing a stake of 25,253 shares — an estimated $72.5K sold.

Susquehanna International Group first reported a position in ANEB in Q1 2024 and held it in 1 quarter. The position peaked at $72.5K in Q1 2024. 13 funds tracked by Wall St. Rank hold ANEB as of Q2 2024.

  • Susquehanna International Group reported no remaining Anebulo Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • Susquehanna International Group sold 25,253 Anebulo Pharmaceuticals shares in Q2 2024, an estimated $72.5K.
  • Susquehanna International Group first reported a position in Anebulo Pharmaceuticals in Q1 2024 and held it in 1 quarter.
  • Susquehanna International Group's Anebulo Pharmaceuticals position peaked at $72.5K in Q1 2024.
  • 13 funds tracked by Wall St. Rank held Anebulo Pharmaceuticals as of Q2 2024.

Based on Susquehanna International Group's 13F filing for Q2 2024, filed 15 Aug 2024.